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Introduction
DNA double-strand breaks (DSBs) arise as products of sto-
chastic replication failure, reactive oxygen species, or because 
of environmental clastogens such as ionizing radiation (IR; 
Löbrich and Jeggo, 2007). DSBs are highly cytotoxic lesions 
and pose extreme demands on coordinating DNA repair with 
vital transactions such as transcription, DNA replication, or 
chromosomal segregation. To safeguard genome integrity 
challenged by DSBs, cells mobilize repair and signaling path-
ways, whose activation and coordination involve damaged 
DNA as well as chromatin composed of histones and histone-
binding proteins (Fernandez-Capetillo et al., 2004; Stucki and 
Jackson, 2006; Jackson and Bartek, 2009; van Attikum and 
Gasser, 2009).
After DSB generation, the neighboring chromatin under-
goes extensive modifications, initiated by the ataxia telangiec-
tasia mutated (ATM)–mediated phosphorylation of the histone 
H2AX (-H2AX) followed by recruitment of the MDC1 adap-
tor (Stucki et al., 2005) and two ubiquitin ligases, RNF8 and 
RNF168 (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 
2007; Wang and Elledge, 2007; Doil et al., 2009; Stewart et al., 
2009). The ensuing chromatin ubiquitylation allows amplifica-
tion of the ATM signaling and local concentration of repair fac-
tors including the BRCA1A complex (van Attikum and Gasser, 
2009). In parallel, the DSB sites undergo local histone eviction 
and enzymatic DNA resection, and the resulting single-stranded 
DNA generates a structural platform for another signaling 
In response to ionizing radiation (IR), cells delay cell cycle progression and activate DNA repair. Both processes are vital for genome integrity, but the 
mechanisms involved in their coordination are not fully 
understood. In a mass spectrometry screen, we identi­
fied the adenosine triphosphate–dependent chromatin­ 
remodeling protein CHD4 (chromodomain helicase 
DNA­binding protein 4) as a factor that becomes tran­
siently immobilized on chromatin after IR. Knockdown 
of CHD4 triggers enhanced Cdc25A degradation and 
p21Cip1 accumulation, which lead to more pronounced 
cyclin­dependent kinase inhibition and extended cell 
cycle delay. At DNA double­strand breaks, depletion of 
CHD4 disrupts the chromatin response at the level of the 
RNF168 ubiquitin ligase, which in turn impairs local ubiq­
uitylation and BRCA1 assembly. These cell cycle and chro­
matin defects are accompanied by elevated spontaneous 
and IR­induced DNA breakage, reduced efficiency of DNA 
repair, and decreased clonogenic survival. Thus, CHD4 
emerges as a novel genome caretaker and a factor that fa­
cilitates both checkpoint signaling and repair events after 
DNA damage.
The chromatin-remodeling factor CHD4 coordinates 
signaling and repair after DNA damage
Dorthe Helena Larsen,1 Catherine Poinsignon,1 Thorkell Gudjonsson,1 Christoffel Dinant,1 Mark R. Payne,2  
Flurina J. Hari,3 Jannie M. Rendtlew Danielsen,1 Patrice Menard,1 Jette Christensen Sand,1 Manuel Stucki,3  
Claudia Lukas,1 Jiri Bartek,1,4 Jens S. Andersen,5 and Jiri Lukas1
1Institute of Cancer Biology and Centre for Genotoxic Stress Research, Danish Cancer Society, DK-2100 Copenhagen, Denmark
2Rolfs Plads 11, 4tv, 2000 Frederiksberg, Denmark
3Institute of Veterinary Biochemistry and Molecular Biology, University of Zürich at Irchel, CH-8057 Zürich, Switzerland
4Institute of Molecular and Translational Medicine, Palacky University, 779 00 Olomouc, Czech Republic
5Center for Experimental Bioinformatics, Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense, Denmark
© 2010 Larsen et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
o
n
 January 15, 2017
D
ow
nloaded from
 
Published August 30, 2010
 http://jcb-dataviewer.rupress.org/jcb/browse/3051
Original image data can be found at: 
/content/suppl/2010/08/23/jcb.200912135.DC1.html 
Supplemental Material can be found at:
 http://jcb-dataviewer.rupress.org/jcb/browse/3051
 
This article has original data in the JCB Data Viewer
o
n
 January 15, 2017
D
ow
nloaded from
 o
n
 January 15, 2017
D
ow
nloaded from
 o
n
 January 15, 2017
D
ow
nloaded from
 o
n
 January 15, 2017
D
ow
nloaded from
 
JCB • VOLUME 190 • NUMBER 5 • 2010 732
ATP-dependent nucleosome remodeling and histone deacety-
lation. The NuRD complex is composed of the chromatin- 
remodeling subunit CHD4/3, HDAC1/2 (histone deacetylase 1 
and 2), RbAp (retinoblastoma-associated protein 46 and 48), 
MBD (methyl-CpG–binding domain–containing protein 2 and 3), 
and MTA1–3 (metastasis-associated proteins 1, 2, and 3; Tong 
et al., 1998; Wade et al., 1998; Xue et al., 1998; Zhang et al., 
1998; Bowen et al., 2004). The NuRD subunits CHD4, CHD3, 
MTA1, and MTA2 all showed a statistically significant increase 
in chromatin binding in response to IR (Fig. 1 C).
CHD4 physically interacts with ATR (Schmidt and 
Schreiber, 1999), and it was recently identified as an ATM/ATR 
phosphotarget on S1349Q in a proteomic screen (Matsuoka et al., 
2007). Consistent with this previously described involvement of 
CHD4 in the main DDR pathways and the mass spectrometry 
data reported herein, we obtained evidence that the IR-induced 
chromatin enrichment of CHD4 can be explained at least in part 
by its retention directly at the sites of DNA damage. Thus, after 
microirradiating cells expressing GFP-CHD4 by a laser under 
conditions that induce DNA strand breaks (Lukas et al., 2003; 
Bekker-Jensen et al., 2006), we observed rapid accumulation of 
GFP-CHD4 at the sites of DNA damage (Fig. 1 D, left). Of note, 
the accumulation of CHD4 at DSBs represented only a fraction 
of the nuclear pool of the protein, the bulk of which remained 
dispersed in the nucleus, indicating a dynamic exchange between 
DSBs and the undamaged parts of the nucleus. Time-lapse analy-
sis revealed that the accumulation of GFP-CHD4 at the DSB 
sites reached half-maximum within 1 min after microirradiation 
(Fig. 1 D, right), a value reminiscent of the earliest DSB inter-
actors (Lukas et al., 2004; Mailand et al., 2007; Doil et al., 2009). 
Collectively, these data are consistent with a role of CHD4 in 
the initial stages of the DDR, and we set out to investigate the 
physiological relevance of these findings.
Knockdown of CHD4 sensitizes cells to IR 
and slows down cell cycle progression
We started by examining the impact of CHD4 on cellular fit-
ness and observed that knockdown of CHD4 reduced colony 
formation of cells exposed to IR (Fig. 2 A). To gain insight into 
the impaired survival, we first followed cell cycle progression. 
Although treating cells with CHD4 siRNAs moderately reduced 
S and G2 compartments in otherwise unstressed cells, com-
bined irradiation and CHD4 depletion had a much more pro-
nounced impact on cell cycle progression. This was manifested 
by a marked S phase delay (Fig. 2 B, 12 h) followed by accu-
mulation of cells in G2 (Fig. 2 B, 24 and 30 h). Furthermore, 
a fraction of CHD4-deficient cells was also clearly arrested in 
G1, an effect that was virtually absent in a control cell popula-
tion treated with an identical dose of IR (Fig. 2 B, compare the 
matching 12- and 24-h time points). Similar consequences of 
CHD4 knockdown were observed after treating irradiated cells 
with an independent siRNA (Fig. S1 A). The extended cell cycle 
checkpoints were further substantiated by a more pronounced 
inhibition of the cyclin A–associated kinase activity (Fig. S1 B), 
decreased DNA replication measured by BrdU incorporation 
(Fig. S1 C), and delayed mitotic entry (Fig. S1 D). Importantly, 
the impact of CHD4 knockdown on cell cycle progression 
module triggered by assembly of the ataxia telangiectasia and 
Rad3 related (ATR) kinase with its coactivators (Bartek and 
Lukas, 2007). All of these events are essential for timely initia-
tion and amplification of the DNA damage signaling.
The signal generated at the DSBs must be transmitted to the 
entire nucleus to delay cell cycle progression (Lukas et al., 2003; 
Bartek et al., 2004). The key signal transducers are the CHK2 and 
CHK1 kinases, which propagate and amplify the pathways initi-
ated by ATM and ATR, respectively. Among targets of CHK1/
CHK2 is the Cdc25A phosphatase, which, when phosphorylated, 
undergoes a proteasome-mediated degradation (Mailand et al., 
2000). This in turn inhibits Cdk2 and Cdk1, the two major kinases 
governing cell cycle progression. This checkpoint pathway is rap-
idly implemented and delays cell cycle for several hours, which in 
most cases, is sufficient to provide time for repair (Bartek et al., 
2004). In parallel, S phase progression can be slowed down also 
by ATM/ATR-mediated phosphorylation of the cohesin SMC1 
(Falck et al., 2002; Kitagawa et al., 2004). Finally, cells possess a 
mechanism to extend checkpoint activity in cases of complex or 
extensive DNA damage. This branch depends on p53, which is 
also targeted by ATM/ATR and CHK2/CHK1 (Bartek and Lukas, 
2007). Phosphorylation of p53 leads to its stabilization and trans-
activation of the p53 targets including the p21Cip1 Cdk inhibitor; 
p21 then reinforces the cell cycle arrest and can maintain it for an 
extended period of time (Kastan and Bartek, 2004).
Despite the recent progress in dissecting the pathways 
involved in DSB repair and signaling, their functional cross 
talk and coordination are not understood. To elucidate these 
issues, we performed an unbiased proteomic screen for factors 
that become specifically enriched on chromatin after IR and 
report on identification of CHD4 (chromodomain helicase 
DNA-binding protein 4) as a new component of the genome 
surveillance machinery.
Results and discussion
Identification of CHD4 as a factor involved 
in the DNA damage response (DDR)
By combining stable isotope labeling with amino acids in cell 
culture (SILAC) labeling (Ong et al., 2002), cellular fraction-
ation, tandem mass spectrometry (Aebersold and Mann, 2003), 
and statistical analysis, we screened the nuclear proteome for 
factors with increased chromatin binding in response to IR. 
Chromatin-bound proteins were enriched by biochemical frac-
tionation including progressive protein extraction by increasing 
salt concentrations, and the most tightly bound proteins were 
solubilized in the pellet fraction (Fig. 1 A). The resulting chro-
matin fractions were analyzed by tandem mass spectrometry. 
We used the statistical method analysis of variance (ANOVA) to 
identify proteins that exhibit DNA damage–induced altered elu-
tion from chromatin, resembling the behavior of proteins such 
as 53BP1 (Fig. 1 B), which is known to bind chromatin in the 
vicinity of the DSB lesions.
Among the statistically highest scoring proteins (99.9% 
confidence level) were several subunits of the nucleosome- 
remodeling and histone deacetylase (NuRD) complex. NuRD 
uniquely couples two chromatin-directed enzymatic functions: 
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Figure 1. Identification of CHD4 as a factor involved in the DDR. (A) Proteomic screening procedure. GM00130 lymphocytes were grown in heavy or 
light SILAC media, exposed to 10 Gy of IR, fractionated, and analyzed by tandem mass spectrometry (MS/MS). LC, liquid chromatography. (B) Box 
plot showing quantitative tandem mass spectrometry data for 53BP1 (positive control). Y axis, normalized ratios (IR peptide/control peptide) showing 
protein elution by progressive salt fractionation of irradiated lymphocytes relative to control lymphocytes. The box represents the central 50% of the 
distributions, and the whiskers approximate the 95% interval. (C) Tandem mass spectrometry data for NuRD subunits are shown. Box plots are as in B. 
(D) Accumulation of GFP-CHD4 at laser-generated DSBs (left) and real-time recruitment of GFP-CHD4 derived from 10 independent cells (right). Error 
bars indicate SEM. Bar, 10 µm.
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Figure 2. Knockdown of CHD4 sensitizes cells to IR and deregulates cell cycle progression. (A) Clonogenic survival assay. U2OS cells were treated with 
control or CHD4 siRNAs (SMARTpool) for 72 h as indicated, irradiated, and colonies with >50 cells were counted. CHD4 down-regulation was monitored 
by immunoblotting. SMC1, loading control. (B) U2OS cells were treated with control or CHD4 siRNA (#2) for 72 h, irradiated (6 Gy), and analyzed at 
the indicated time points by flow cytometry. (C) U2OS cells were treated with control or CHD4 siRNAs (SMARTpool), treated with ATM inhibitor for 1.5 h, 
irradiated, and analyzed by flow cytometry. The efficiency of CHD4 siRNAs in B and C is shown in Fig. S3 B. (D) U2OS cell lines conditionally express-
ing GFP or GFP-CHD4 resistant to siRNA (#3) were treated with control or CHD4 siRNA (#3) as indicated. After 48 h, the transgenes were induced by 
addition of doxycycline after an additional 24 h, irradiated, and analyzed by flow cytometry. To compensate for minor differences in the starting S phase 
content in the two cell lines, the data were normalized and are presented as the ratios between the S phase content measured 10 h after IR (T10) and that 
in unirradiated cells (T0). The GFP-CHD4 cell line and the efficiency of siRNA (#3) are characterized in Fig. S1 E. Error bars indicate SEM.
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CHD4-deficient conditions. Thus, using pulsed field gel electro-
phoresis (PFGE; Hanada et al., 2007), we detected an increased 
amount of DSBs in CHD4-deficient cells immediately after IR 
exposure (Fig. 3 C, compare lane 2 with lane 7; and Fig. S2 E). 
Of note, the elevated amount of DSBs in CHD4-depleted cells re-
mained apparent during the first 2 h after IR (Fig. 3 C, compare 
involved bona fide DNA damage signaling, demonstrated by the 
reversal of the S phase accumulation by treating the cells with 
a specific inhibitor of ATM (Fig. 2 C). Finally, reintroducing 
siRNA-resistant GFP-CHD4 into cells depleted of endogenous 
CHD4 reversed the S phase accumulation, arguing against off-
target effects of the siRNA treatment (Fig. 2 D and Fig. S1 E).
Elevated checkpoint signaling in the 
absence of CHD4
To understand the reasons for these cell cycle aberrations, we ex-
amined the critical components of the genome surveillance path-
ways. Consistent with the aforementioned cell cycle delay, we 
observed that the Cdc25A phosphatase, the key effector of rap-
idly deployed cell cycle checkpoints, became degraded and re-
mained low in the absence of CHD4, even at stages when Cdc25A 
in control cells recovered to predamage levels (Fig. 3 A). We could 
confirm that the absence of Cdc25A recovery in CHD4-deficient 
cells was caused by ongoing protein degradation and not by re-
duced mRNA expression (Fig. S2, A and B). Together, these data 
indicate that in the absence of CHD4, the rapid checkpoint re-
sponse lasts longer than in CHD4-proficient cells.
Because CHD4-depleted cells responded to IR also by a 
G1 and G2 accumulation (Fig. 2 B), we examined the p53–p21 
axis that plays an important role in sustaining the cell cycle 
arrest at these crucial transitions. Interestingly, knocking down 
CHD4 triggered p21 accumulation already in unstressed cells, 
and this further increased after exposing the cells to IR (Fig. 3 B 
and Fig. S2 C). Such p21 elevation was associated with a pro-
gressive dephosphorylation of pRb, an established surrogate 
of Cdk inhibition (Fig. 3 B). In addition, the IR-induced induc-
tion of p21 was p53 dependent (Fig. S2 D), and it was consis-
tently more robust and occurred earlier in CHD4-depleted cells 
(Fig. 3 B and Fig. S2 C). We conclude that the sustained branch of 
the DNA damage–induced checkpoint signaling is more robust 
in CHD4-depleted cells and that it is partially activated already 
before exposing cells to external genotoxic stress.
CHD4-deficient cells transiently 
hyperactivate ATM and ATR
Consistent with the extended Cdc25A degradation, both ATM- 
(ATMS1981-P, -H2AX, and SMC1S966-P) and ATR-mediated 
(CHK1S317-P and CHK1S345-P) signaling were elevated to supra-
physiological levels in the absence of CHD4, an effect that was 
most evident on increased -H2AX (Fig. 3 A and Fig. S2 C). 
This spike of ATM/ATR phosphorylations was restricted to the 
early stages of DDR (≤1 h after IR) and was consistently ob-
served after knocking down CHD4 with independent siRNAs 
targeting distinct regions of the CHD4 transcript (Fig. 3 A and 
Fig. S2 C). Two scenarios could explain the enhanced ATM/
ATR activities. First, depletion of CHD4 may cause local chro-
matin changes that increase the signaling from a similar amount 
of DNA breaks as generated in control cells. Second, CHD4 
depletion may result in more widespread chromatin modifica-
tions that poise it to accumulate more breaks when exposed to 
IR. Although these scenarios are not mutually exclusive, we ob-
tained evidence that the latter might represent the source of the 
transient spike of the ATM/ATR-mediated phosphorylations in 
Figure 3. Extended checkpoint signaling in the absence of CHD4.  
(A) U2OS cells were treated with control or CHD4 siRNAs (SMARTpool) 
for 72 h, irradiated, and analyzed by immunoblotting with antibodies and 
at the specified time points. (B) U2OS cells were treated with siRNAs as 
in A, irradiated, and analyzed by immunoblotting. Asterisk, nonspecific 
band; arrow, CHD4. (A and B) Total SMC1, loading control. (C) U2OS 
were treated with control or CHD4 siRNAs (SMARTpool) for 72 h and 
irradiated. The DNA breakage was analyzed by PFGE at the indicated 
time points (top). The relative densities of the DSB bands (bottom) were 
normalized to the value measured in nonirradiated cells treated with con-
trol siRNA (lane 1).
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Figure 4. Impaired ubiquitylation and delayed accumulation of BRCA1 at the site of DSBs in the absence of CHD4. (A–D) U2OS cells were treated with con-
trol (CTR) or CHD4 siRNAs (SMARTpool) for 72 h, microirradiated by the laser, and immunostained with antibodies to BRCA1 (A), RNF8 (B), RNF168 (C), 
and conjugated ubiquitin (FK2 antibody; D). Cells were coimmunostained with antibodies to -H2AX (A–C) or MDC1 (D) to mark the DSB-containing tracks. 
(left) Representative fields for each DSB regulator (A–C, acquired 8 min after microirradiation; D, acquired 15 min after microirradiation) are shown. (right) 
Graphs show quantification of relative fluorescence intensities in the microirradiated areas subtracted by the background fluorescence in the undamaged 
parts of the nucleus. The efficiency of CHD4 siRNAs in A–D is shown in Fig. S3 B. RFU, relative fluorescence units. Error bars indicate SD. Bar, 10 µm.
lanes 3 and 4 with lanes 8 and 9, respectively), indicating that 
CHD4-deficient cells have reduced ability to repair DSBs. 
Finally, the PFGE assay revealed reproducible DSB generation 
even in nonirradiated CHD4-depleted cells, an effect evident 
especially after quantitatively knocking down CHD4 by the 
most efficient siRNA (#2; Fig. S2 E). This is consistent with 
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a recent study reporting that the physiological loss of the NuRD 
complex in senescent cells is accompanied by a progressive in-
crease of spontaneous DNA damage (Pegoraro et al., 2009).
Knockdown of CHD4 impairs retention  
of repair proteins at the sites of  
DNA damage
To gain more insight into mechanisms that might be subverted 
by NuRD disruption, we turned to the earlier observation that a 
fraction of CHD4 accumulates directly at the DSB sites (Fig. 1 D) 
and asked whether this influences accumulation of proteins 
in this compartment. Interestingly, accumulation of BRCA1, a 
key genome caretaker involved in DSB signaling and repair, was 
consistently impaired in early phases of the DSB response in 
CHD4-depleted cells (Fig. 4 A). This was unexpected because the 
extent of H2AX phosphorylation (an upstream prerequisite for 
BRCA1 retention on damaged chromatin) was more pronounced 
in CHD4-deficient cells (Fig. 3 A and Fig. S2 C). Importantly, 
these observations were not restricted to the laser-induced DNA 
lesions; the transient impairment of BRCA1 focus formation 
was also observed in irradiated cells treated with two independent 
siRNAs against CHD4 (Fig. S3 A).
Because the BRCA1 requires binding to conjugated ubiq-
uitin for its accumulation at DSBs, we tested the impact of 
CHD4 knockdown on RNF8 and RNF168, the two key ubiqui-
tin ligases involved in this process. Strikingly, although RNF8 
remained stable and robustly accumulated at DSBs regardless of 
the CHD4 status (Fig. 4 B and Fig. S3 B), RNF168 was partially 
destabilized, and its retention of RNF168 was attenuated in 
CHD4-depleted cells (Fig. 4 C and Fig. S3 B). Correspondingly, 
generation of ubiquitin conjugates at the microlaser-generated 
DSBs was reduced (Fig. 4 D). Together, these data suggest that 
the transition from the RNF8- to RNF168-controlled step in 
the DSB-induced chromatin response might be more complex 
than originally thought (Doil et al., 2009; Stewart et al., 2009). 
For instance, we can envisage that the transient recruitment of 
CHD4 to the DSB sites (and the ensuing chromatin remodeling) 
allows more efficient recognition of the nascent ubiquitin chains 
(generated by RNF8) by the ubiquitin-binding domains of 
RNF168, which would in turn facilitate RNF168 recruitment 
and amplification of the local ubiquitin reaction.
Model of the CHD4 involvement 
in protecting the genome against 
chromosomal breakage
Large-scale genetic and biochemical surveys suggested a role of the 
NuRD chromatin-remodeling complex in the DDR (van Haaften 
et al., 2006; Matsuoka et al., 2007). In this study, we provide addi-
tional and complementary evidence from an unbiased proteomic 
screen in which we identified four distinct subunits of the NuRD 
complex among proteins that gain affinity to chromatin damaged 
by IR. In addition, our study and an accompanying paper in this 
issue by Smeenk et al. report the first set of functional analyses 
that delineate the consequences of CHD4 disruption for genome 
surveillance. Among the salient alterations in CHD4-deficient 
cells are decreased clonogenic survival, supraphysiological in-
crease of ATM/ATR signaling, protracted cell cycle checkpoints 
after IR, and delayed assembly of a subset of repair factors at the 
sites of DNA damage. In addition, we consistently observed that 
reduction of cellular levels of CHD4 is accompanied by spontane-
ous DNA damage. Molecular explanations of these diverse defects 
are likely complex, and our data indicate that disruption of CHD4 
may deregulate DDR at multiple levels (Fig. 5).
First, the decreased stability and impaired accumulation 
of RNF168 at DSBs, the reduced local chromatin ubiquity-
lation, and the impaired accumulation of BRCA1 on damaged 
chromosomes likely attenuate the DNA repair efficiency and 
thereby contribute to the increased IR sensitivity in CHD4- 
deficient cells. The compromised DNA repair under such condi-
tions might also contribute to the extended cell cycle checkpoints 
caused by continuous presence of unrepaired DNA and chroma-
tin intermediates that amplify ATR and ATM signaling. Such a 
protracted cell cycle arrest, when extended over certain threshold, 
may undermine viability for instance by inducing cell death or 
allowing checkpoint adaptation followed by mitotic entry with 
unrepaired DSBs (Syljuåsen et al., 2006).
However, recent development in the field and results in 
this study indicate that the local events at the DSB sites cannot 
explain the entire complexity of phenotypes observed in CHD4- 
deficient cells. Most notably in this regard, the prolonged 
S phase, transient spike of ATM/ATR signaling after IR, and 
spontaneous DNA damage were not readily observed in experi-
ments analyzing the currently known factors associated with the 
Figure 5. A proposed model of CHD4 involvement in genome mainte-
nance. See Results and discussion for details.
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Raw individual peptide ratios were normalized by dividing by the median 
value, calculated across all three chromatin fractions; the final value is 
therefore the abundance of a peptide in the treated samples, relative to 
the untreated, in which a value of 1 corresponds to equivalent amounts. 
For each individual protein, ANOVA was used as a large-scale screening 
technique to identify proteins that showed a statistically significant varia-
tion in the elution profile, i.e., under the null hypothesis of each chromatin 
fraction in the elution profile having the same mean. Normalized peptide 
ratios were assumed to be log-normally distributed about the mean, and 
were therefore log (ln)-transformed before analysis: applying the Shapiro-
Wilks test for normality on the log-transformed ratios showed that this as-
sumption could not be rejected at the 95% level for the majority (92%) of 
proteins. The ANOVA was then performed using the R statistical package 
(http://www.r-project.org). Proteins in which the null hypothesis could be 
rejected at the 99% level were identified as candidates.
Plasmids and transfections
The expression plasmids for CHD4 were generated by inserting PCR-amplified 
CHD4 cDNA in frame into either pcDNA3.1-HA or pcDNA4TO-GFP. 
siRNA-resistant form of CHD4 was generated using the QuickChange site-
directed mutagenesis kit (Agilent Technologies) with the oligonucleotides 
(forward) 5-CGGCCAGAGCGGCAATTTTTCGTGAAATGGCAAGGC-3 
and (reverse) 5-GCCTTGCCATTTCACGAAAAATTGCCGCTCTGGCCG-3. 
Plasmid transfections were performed using FuGENE 6 according to the 
manufacturer’s recommendations (Roche).
RNA interference
The siRNA oligonucleotides were obtained from Thermo Fisher Scientific 
(SMARTpool of four oligonucleotides) and MWG Biotech (individual siRNAs). 
The annotations and sequences of the siRNA oligonucleotides were as 
follows (sense strands): (#1) 5-GAAUAAAUUUCUAGCUCGAUU-3, (#2) 
5-GGUGUUAUGUCUUUGAUUCUU-3, (#3) 5-GAGCGGCAGUUCUUU-
GUGAUU-3, and (#4) 5-AAGAAGAUCUAGCCCGAAAUU-3.
All siRNA transfections were performed with 100 nM siRNA du-
plexes using Lipofectamine RNAiMAX (Invitrogen). Cells were transfected 
by siRNAs 24 and 48 h after plating. Transfection reagents and remaining 
oligonucleotides were washed off 6 h after treatment. Samples were har-
vested 72 h after initiation of transfection unless stated otherwise. Control 
siRNA (5-GGGAGGACAAGACGUUCUA-3) was against HSP70B (Leung 
et al., 1990), a variant of the human heat shock protein that is not expressed 
in U2OS cells. For complementation assays, oligonucleotide duplex #3 
was used by transient transfection.
Cell culture
Human U2OS osteosarcoma cells and 293T human embryonic kidney 
cells were grown in DME containing 10% fetal bovine serum (Invitrogen), 
100 U penicillin, and 100 µg/ml streptomycin. GM00130 (Coriell Cell 
Repositories) Epstein-Barr virus–transformed B-lymphocytes were cultured 
in RPMI1640 and GlutaMAX (Invitrogen) containing 15% serum, 100 U 
penicillin, and 100 µg/ml streptomycin. Where indicated, the culture me-
dium was supplied with 5 mM of the proteasome inhibitor MG132 (EMD) 
or 10 µM ATM inhibitor (KU55933; Kudos Pharmaceuticals). For SILAC 
experiments, cells were grown for at least five cell divisions in l-lysine– and 
l-arginine–deficient RPMI1640 and GlutaMAX containing 15% dialyzed 
serum and either normal isotopes or 2H4-lysine/13C6-arginine, also referred 
to as light and heavy, respectively. U2OS derivative cell lines expressing 
GFP-CHD4 protein in a doxycycline-responsive manner were isolated by 
cotransfecting U2OS cells with pcDNA6/TR (Invitrogen) and pcDNA4/
TO-GFP-CHD4 constructs and selecting productively transfected cells with 
400 µg/ml zeocin and 5 µg/ml blasticidin S (Invitrogen).
Generation of DNA damage
IR was delivered by an x-ray generator (150 kV; 15 mA; 2.18 Gy/min 
dose rate; HF160; Pantak). Laser microirradiation and real-time recording 
was performed as described previously (Lukas et al., 2003, 2004). Typi-
cally, a mean of 150 cells were microirradiated for each experiment.
BrDU incorporation
Cells were labeled for 10 min with 25 µM BrdU (Sigma-Alrich), fixed in 4% 
formaldehyde solution (VWR) and permeabilized with 0.2% Triton X-100. 
Samples were treated with DNase (Roche) for 30 min at room temperature 
and immunostained according to the manufacturer’s instruction.
Antibodies
Rabbit polyclonal antibodies used in this study included CHK1 phospho-
S317 (2344; Cell Signaling Technology), CHK1 phospho-S345 (2341; 
DSB-flanking chromatin. Based on our PFGE results, we propose 
that the latter consequences of CHD4 depletion reflect at least in part 
more global alterations of higher-order chromatin structure. This in 
turn can render chromatin vulnerable and prone to accumulate more 
breaks. In support of such a scenario, a recent study (Pegoraro et al., 
2009) showed that loss of NuRD components during premature 
and physiological ageing induced alterations of the higher order 
chromatin structure accompanied by increased spontaneous DNA 
damage. Moreover, the genome-protective role of heterochroma-
tin seems to be conserved throughout evolution, indicated by an-
other recent study showing that loss of heterochromatin-associated 
histone methylations in Drosophila melanogaster also leads to spon-
taneous DNA damage, checkpoint activation, and chromosomal in-
stability (Peng and Karpen, 2009). Interestingly, the NuRD complex 
(specifically its MBD3 subunit) was shown to facilitate deposition 
and stability of epigenetic marks including the heterochromatin- 
associated histone methylations (Morey et al., 2008). Thus, in addi-
tion to facilitating local assembly of repair factors directly at DSBs 
(and thereby directly contributing to repair efficiency), the NuRD 
complex may contribute to genome maintenance by organizing po-
tentially vulnerable segments of eukaryotic genomes (such as the 
heterochromatin-associated repetitive sequences; Peng and Karpen, 
2009) to a state that makes them more resilient to adverse effects of 
stochastic or clastogen-induced DNA breakage.
Materials and methods
Peptide preparation and tandem mass spectrometry
Proteins extracted from chromatin preparations were dissolved in LDS sam-
ple buffer, heated for 10 min at 70°C, reduced with DTT, and alkylated with 
iodoacetamide. Proteins were separated by electrophoresis on NuPAGE 
Bis-Tris 4–12% gradient gels (Invitrogen) and stained with Coomassie blue. 
Gel slices (10 slices) were cut into small pieces, washed several times with 
20 mM ammonium bicarbonate and 50% acetonitrile, and incubated with 
12.5 ng/µl endoprotease trypsin in 20 mM ammonium bicarbonate at 
37°C overnight. The resulting peptides were extracted with 1% trifluoro-
acetic acid desalted on STAGE tips, and eluted into 96-well plates for mass 
spectrometric analysis.
Mass spectrometry and peptide identification and quantitation
Mass spectrometry was performed by liquid chromatography mass spec-
trometry using an HP1100 system (Agilent Technologies) and a linear ion-
trap Fourier-transform ion cyclotron resonance mass spectrometer (Thermo 
Fisher Scientific). Peptides were separated by a 120-min linear gradient of 
95% buffer A (0.5% acetic acid in water) to 50% buffer B (80% acetonitrile 
and 0.5% acetic acid in water). The linear ion-trap Fourier-transform ion 
cyclotron resonance instrument was operated in the data-dependent mode 
to acquire high-resolution precursor ion spectra (m/z 300–1,500; resolution 
50,000; and ion accumulation to a target value of 3 × 106 ions) in the ion 
cyclotron resonance cell. The three most intense ions were sequentially iso-
lated for accurate mass measurements by selected ion monitoring (SIM) 
scans (10-D mass window; resolution 50,000; and a target accumulation 
value of 50,000). The ions were simultaneously fragmented in the linear ion 
trap with a normalized collision energy setting of 27% and a target value of 
10,000. Peak lists were extracted using MSQuant, an in-house developed 
open source application (http://msquant.sourceforge.net), and used for 
searches in the International Protein Index sequence database using Mascot 
(Matrix Science). MSQuant was also used to calculate peptide isotope ratios 
and to evaluate the certainty in peptide identification and quantitation based 
on Mascot score and MS3 scoring or by manual inspection. Initially, all pep-
tides with a Mascot score of ≥20 were quantified automatically.
Data analysis
The quantified peptide ratios were analyzed through the use of a statistical 
analysis in which each individual peptide ratio was considered to be an in-
dependent estimate of the relative abundance of the corresponding protein. 
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in loading sample buffer (50 mM Tris, pH 6.8, 100 mM DTT, 2% SDS, 0.1% 
Bromophenol blue, and 10% glycerol), boiled for 5 min, and sonicated.
Kinase assay
After standard immunoprecipitation, beads were washed two times in 
kinase buffer (50 mM Hepes, pH 7.5, 10 mM MgCl2, 2.5 mM EGTA, 
10 mM -glycerolphosphate, 1 mM NAF, 1 mM DTT, and 0.1 mM 
Na3VO4). 30 µl kinase reaction mix (18 µl kinase buffer, 75 µM cold ATP, 
2 µg protein H1, and 10 µCi -[32P] ATP) was added and incubated for 
30 min at 30°C with interval shaking. Samples were analyzed using 12% 
SDS-PAGE followed by Coomassie staining and drying, and the signal was 
quantified using a phosphoimager.
Clonogenic survival assay
U2OS cells were untreated or transfected with control or CHD4 siRNA. 2 d 
after transfection, between 100 and 2,000 cells (depending on radiation 
dose to yield 30–200 colonies per dish) were seeded to 6-cm-diameter 
dishes, incubated for 20–24 h, and treated with IR (0, 2, 3, or 4 Gy). 
Subsequently, cells were incubated for an additional 10 d and stained 
with crystal violet. Colonies containing >50 cells were scored as survivors. 
Survival fractions were calculated in each experiment as the mean cloning 
efficiency (from at least two parallel dishes) after treatment corrected for 
plating efficiency.
PFGE
Optimized PFGE protocol allowing quantitative detection of DSBs already 
in a range of 10 Gy of IR was performed as described previously (Hanada 
et al., 2007). In brief, U2OS cells were treated with indicated siRNAs 
on two sequential days. After 72 h, cells were either irradiated or left un-
treated, trypsinized, and agarose plugs 5 × 105 cells were prepared with 
a CHEF disposable plug mold (Bio-Rad Laboratories). Plugs were incubated 
in lysis buffer (100 mM EDTA, 0.2% sodium deoxycholate, 1% sodium 
laurylsarcosine, and 1 mg/ml proteinase K) for 40 h at 37°C. After wash-
ing with TE buffer (10 mM Tris, pH 8.0, and 100 mM EDTA), plugs were 
embedded into a 0.9% agarose gel. Electrophoresis was performed in 
TBE buffer with the following parameters: (block I) 9 h, 120° angle, 
5.5 V/cm voltage, 30–18-s interval; (block II) 6 h, 117° angle, 4.5 V/cm 
voltage, 18–9-s interval; (block III) 6 h, 112° angle, 4 V/cm voltage, 9–5-s 
interval. The gel was stained with ethidium bromide.
Real-time PCR
Real-time PCR was performed as described previously (Löffler et al., 2003) 
with the following primer sequences: Cdc25A, (sense) 5-ACCGTCACTAT-
GGACCAGC-3 and (antisense) 5-TTCAGAGCTGGACTACATCC-3; and 
porphobilinogen deaminase, (sense) 5-TCCAAGCGGAGC-CATGTCTG-3  
and (antisense) 5-AGAATCTTGTCCCCTGTGGTGGA-3.
Online supplemental material
Fig. S1 provides additional evidence for extended cell cycle delay in 
CHD4-depleted cells exposed to IR. Fig. S2 shows impact of CHD4 deple-
tion on checkpoint signaling and DNA repair. Fig. S3 shows impaired 
BRCA1 retention at IR-induced nuclear foci and partial destabilization of 
RNF168 in CHD4-deficient cells. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200912135/DC1.
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Figure S1.  Down-regulation of CHD4 delays cell cycle progression after IR. (A) U2OS cells were treated with CHD4 siRNA (#1) for 72 h, irradiated (6 Gy), 
and analyzed at the indicated time points by flow cytometry. The control DNA profiles of cells treated with nonspecific siRNA are provided in Fig. 2 B. 
The efficiency of the CHD4 siRNAs is shown in Fig. S3 B. The G1 arrest and S phase delay (the latter manifested as a broader peak above the 4N DNA 
content) are evident especially at the 12-h time point (arrow). (B) U2OS cells were treated with control or CHD4 siRNAs (SMARTpool) for 72 h, irradiated 
(6 Gy), and analyzed for the cyclin A–associated kinase activity using histone H1 as a substrate at the indicated time points. The values represent ratios 
of the phosphate incorporation relative to that measured in nonirradiated cells. (C) U2OS cells were treated with siRNAs as in B, irradiated (6 Gy), incu-
bated for 13 h, pulse labeled for 10 min with BrdU, and analyzed by immunostaining with anti-BrdU antibody. Bar, 10 µm. (D) U2OS cells were treated 
with siRNAs as in B, irradiated (6 Gy), incubated for 13 h, treated with nocodazole, and the mitotic cells were collected at the indicated time points. 
Cells were subsequently coimmunostained for the mitotic marker phospho-S10 of histone H3 antibody and PI (the total DNA content) and analyzed using 
flow cytometry. (E) U2OS cell line engineered to conditionally express GFP-CHD4 resistant to siRNA (#3) was treated with control or CHD4 siRNA (#3) 
as indicated. After 48 h, the transgenes were induced by addition of doxycycline. After additional 24 h, cells were exposed to IR and analyzed at the 
indicated time points by an antibody to CHD4. Note that the GFP-CHD4 protein resists the siRNA treatment and remains expressed throughout the time 
course. Error bars indicate SEM.
JCB S2
Figure S2.  Impact of CHD4 depletion on checkpoint signaling and cellular response to DNA damage. (A) U2OS cells were treated with control or CHD4 
siRNAs (SMARTpool) as indicated. After 72 h, the cells were treated or not with 5 mM of the proteasome inhibitor MG132 for 30 min, irradiated (6 Gy), 
and analyzed for the Cdc25A protein levels by immunoblotting. (B) U2OS cells were treated with siRNAs as in A, irradiated (10 Gy), and harvested at the 
indicated time points. The Cdc25A mRNA was quantified by RT-PCR, and the data are plotted as ratios relative to the housekeeping gene porphobilinogen 
deaminase. Experiments were performed in duplicate. (C) U2OS cells were transfected with control siRNA or two distinct siRNAs to CHD4 as indicated. 
After 72 h, cells were irradiated and analyzed by immunoblotting with antibodies at the indicated time points. The efficiency of the CHD4 siRNAs is shown 
in Fig. S3 B. Asterisk, nonspecific band. (D) U2OS/p53DD cell line engineered to conditionally express the dominant-negative fragment of p53 was treated 
with control (ctrl) or CHD4 siRNAs (SMARTpool), and 48 h later, induced by removal of tetracycline (Tet) to express the transgene. After an additional 24 h, 
cell were irradiated and analyzed by immunoblotting at the indicated time points. (A, C, and D) Total SMC1 serves as loading control. (E) U2OS cells were 
treated with the indicated siRNAs, irradiated, and subjected to the PFGE analysis as in Fig. 3 C. The efficiency of CHD4 siRNAs is shown in Fig. S3 B. 
Error bars indicate SEM.
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Figure S3.  Impaired BRCA1 retention at IR-induced DSBs in CHD4-deficient cells. (A) U2OS cells were treated with control siRNA or two distinct CHD4 
siRNAs as indicated, incubated for 72 h, irradiated (5 Gy), and immunostained with antibodies to BRCA1 at the indicated time points. The number 
of IR-induced BRCA1 foci per nucleus was determined as described in Materials and methods. The siRNA efficiencies are shown below the blots in B. 
Error bars indicate SD. (B) Ablation of CHD4 partially destabilizes RNF168. U2OS cells were treated with the indicated siRNAs for 72 h and analyzed by 
immunoblotting for accumulation of all chromatin-associated proteins whose recruitment to DSBs was measured in Fig. 4. Note that although BRCA1 and 
RNF8 levels remained unchanged, the levels of RNF168 decreased to some extent in the absence of CHD4. The relative densities of the RNF168 band, 
normalized to the values in cells treated with control siRNA, are indicated below the blots. Tubulin and SMC1 serve as loading controls.
